Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Rangering i aksjer #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Aksjekurs
$154.51
Markedsverdi
$55.98B
Endring (1 dag)
-1.82%
Endring (1 år)
-32.08%
Land
US
Handel Becton, Dickinson and Company (BDX)

Kategori

EPS for Becton, Dickinson and Company (BDX)
EPS per December 2025 TTM: $6.13
Ifølge de siste økonomiske rapportene og aksjekursen til Becton, Dickinson and Company er selskapets nåværende EPS (TTM) $6.13. Ved slutten av 2024 hadde selskapet en EPS på $5.88, en økning sammenlignet med EPS-en i 2023 som var $4.97.
EPS-historikk for Becton, Dickinson and Company fra 2000 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $6.13 4.97%
2025 $5.84 -0.68%
2024 $5.88 18.31%
2023 $4.97 -16.19%
2022 $5.93 -14.31%
2021 $6.92 151.64%
2020 $2.75 -30.56%
2019 $3.96 538.71%
2018 $0.62 -86.81%
2017 $4.70 2.40%
2016 $4.59 33.82%
2015 $3.43 -44.05%
2014 $6.13 -7.54%
2013 $6.63 18.60%
2012 $5.59 -2.78%
2011 $5.75 2.31%
2010 $5.62 9.77%
2009 $5.12 11.06%
2008 $4.61 27.00%
2007 $3.63 19.41%
2006 $3.04 5.92%
2005 $2.87 55.14%
2004 $1.85 -13.55%
2003 $2.14 15.68%
2002 $1.85 19.35%
2001 $1.55 0.65%
2000 $1.54 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$8.01 30.67%
US
$0.53 -91.39%
DE
$4.72 -22.92%
JP
$1.99 -67.54%
CH
$10.15 65.58%
US